Weight Loss & MetabolicPeer Reviewed
Naringin mitigates liver damage in a tissue-engineered liver of metabolic dysfunction-associated steatotic liver disease model by promoting autophagy via the mTOR-ULK1 pathway.
Authors (6)
Jihui Jia
Yizhi ZhangDepartment of critical liver diseases, Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Jing LinFourth Department of Liver Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Zhongping DuanFourth Department of Liver Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Molecular biology reports
Unknown
Published
Oct 13, 2025
Abstract
Abstract not available - data parsing issue resolved
Keywords
AutophagyMetabolic dysfunction-associated steatotic liver diseaseNaringinOrganoidTissue-engineered liver
Article Metrics
Sourcepubmed
Related Research
Explore more articles in this research category to discover related studies and findings.